Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients

Aspects of the present invention provide compositions and methods for prognosis of, and/or predicting the estrogen treatment outcome of breast cell proliferative disorder patients, and in particular of patients with breast carcinoma. In preferred embodiments, this is achieved, at least in part, by d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LESCHE RALF, NIMMRICH INKO, LUKAS ANTJE KLUTH, HARTMANN OLIVER, MARX ALMUTH, MAIER SABINE, SCHWOPE INA
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LESCHE RALF
NIMMRICH INKO
LUKAS ANTJE KLUTH
HARTMANN OLIVER
MARX ALMUTH
MAIER SABINE
SCHWOPE INA
description Aspects of the present invention provide compositions and methods for prognosis of, and/or predicting the estrogen treatment outcome of breast cell proliferative disorder patients, and in particular of patients with breast carcinoma. In preferred embodiments, this is achieved, at least in part, by determining the expression level of PITX2, and/or the genetic or the epigenetic modifications of the genomic DNA associated with the gene PITX2. Additional aspects of the invention provide novel sequences, oligomers (e.g., oligonucleotides or peptide nucleic acid (PNA)-oligomers), and antibodies, which have substantial utility in the described inventive methods and compositions.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2009269736A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2009269736A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2009269736A13</originalsourceid><addsrcrecordid>eNqNjcEKwjAQRHvxIOo_LHgWtYVKjyKKR0E9l5hsJJhmy-6a7zeCH-BpGHjzZlrlC9MzkWiwMBh-IQt4YhgZXbAaKAF5UEajAyYFRhkpCYJJbl04eXMO2cQv9SiUKFiMsewpBo9sNGQEF4TYYdGWXjQyrybeRMHFL2fV8nS8Hc4rHKkvF8ZiQu3v13qz6eq22zXtftv8R30A6T9Hyw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients</title><source>esp@cenet</source><creator>LESCHE RALF ; NIMMRICH INKO ; LUKAS ANTJE KLUTH ; HARTMANN OLIVER ; MARX ALMUTH ; MAIER SABINE ; SCHWOPE INA</creator><creatorcontrib>LESCHE RALF ; NIMMRICH INKO ; LUKAS ANTJE KLUTH ; HARTMANN OLIVER ; MARX ALMUTH ; MAIER SABINE ; SCHWOPE INA</creatorcontrib><description>Aspects of the present invention provide compositions and methods for prognosis of, and/or predicting the estrogen treatment outcome of breast cell proliferative disorder patients, and in particular of patients with breast carcinoma. In preferred embodiments, this is achieved, at least in part, by determining the expression level of PITX2, and/or the genetic or the epigenetic modifications of the genomic DNA associated with the gene PITX2. Additional aspects of the invention provide novel sequences, oligomers (e.g., oligonucleotides or peptide nucleic acid (PNA)-oligomers), and antibodies, which have substantial utility in the described inventive methods and compositions.</description><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; ENZYMOLOGY ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20091029&amp;DB=EPODOC&amp;CC=US&amp;NR=2009269736A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20091029&amp;DB=EPODOC&amp;CC=US&amp;NR=2009269736A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LESCHE RALF</creatorcontrib><creatorcontrib>NIMMRICH INKO</creatorcontrib><creatorcontrib>LUKAS ANTJE KLUTH</creatorcontrib><creatorcontrib>HARTMANN OLIVER</creatorcontrib><creatorcontrib>MARX ALMUTH</creatorcontrib><creatorcontrib>MAIER SABINE</creatorcontrib><creatorcontrib>SCHWOPE INA</creatorcontrib><title>Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients</title><description>Aspects of the present invention provide compositions and methods for prognosis of, and/or predicting the estrogen treatment outcome of breast cell proliferative disorder patients, and in particular of patients with breast carcinoma. In preferred embodiments, this is achieved, at least in part, by determining the expression level of PITX2, and/or the genetic or the epigenetic modifications of the genomic DNA associated with the gene PITX2. Additional aspects of the invention provide novel sequences, oligomers (e.g., oligonucleotides or peptide nucleic acid (PNA)-oligomers), and antibodies, which have substantial utility in the described inventive methods and compositions.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>ENZYMOLOGY</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjcEKwjAQRHvxIOo_LHgWtYVKjyKKR0E9l5hsJJhmy-6a7zeCH-BpGHjzZlrlC9MzkWiwMBh-IQt4YhgZXbAaKAF5UEajAyYFRhkpCYJJbl04eXMO2cQv9SiUKFiMsewpBo9sNGQEF4TYYdGWXjQyrybeRMHFL2fV8nS8Hc4rHKkvF8ZiQu3v13qz6eq22zXtftv8R30A6T9Hyw</recordid><startdate>20091029</startdate><enddate>20091029</enddate><creator>LESCHE RALF</creator><creator>NIMMRICH INKO</creator><creator>LUKAS ANTJE KLUTH</creator><creator>HARTMANN OLIVER</creator><creator>MARX ALMUTH</creator><creator>MAIER SABINE</creator><creator>SCHWOPE INA</creator><scope>EVB</scope></search><sort><creationdate>20091029</creationdate><title>Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients</title><author>LESCHE RALF ; NIMMRICH INKO ; LUKAS ANTJE KLUTH ; HARTMANN OLIVER ; MARX ALMUTH ; MAIER SABINE ; SCHWOPE INA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2009269736A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2009</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>ENZYMOLOGY</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>LESCHE RALF</creatorcontrib><creatorcontrib>NIMMRICH INKO</creatorcontrib><creatorcontrib>LUKAS ANTJE KLUTH</creatorcontrib><creatorcontrib>HARTMANN OLIVER</creatorcontrib><creatorcontrib>MARX ALMUTH</creatorcontrib><creatorcontrib>MAIER SABINE</creatorcontrib><creatorcontrib>SCHWOPE INA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LESCHE RALF</au><au>NIMMRICH INKO</au><au>LUKAS ANTJE KLUTH</au><au>HARTMANN OLIVER</au><au>MARX ALMUTH</au><au>MAIER SABINE</au><au>SCHWOPE INA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients</title><date>2009-10-29</date><risdate>2009</risdate><abstract>Aspects of the present invention provide compositions and methods for prognosis of, and/or predicting the estrogen treatment outcome of breast cell proliferative disorder patients, and in particular of patients with breast carcinoma. In preferred embodiments, this is achieved, at least in part, by determining the expression level of PITX2, and/or the genetic or the epigenetic modifications of the genomic DNA associated with the gene PITX2. Additional aspects of the invention provide novel sequences, oligomers (e.g., oligonucleotides or peptide nucleic acid (PNA)-oligomers), and antibodies, which have substantial utility in the described inventive methods and compositions.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2009269736A1
source esp@cenet
subjects BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
VINEGAR
WINE
title Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T13%3A56%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LESCHE%20RALF&rft.date=2009-10-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2009269736A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true